Maryland Prescription Drug Affordability Board

​Announcements

• UPCOMING MEETING: The Prescription Drug Affordability Board Meeting that was canceled on January 26, 2026 has been rescheduled to February 23, 2026 at 9:00 AM ET. Meeting information can be found here.​ 

• UPCOMING MEETING: ​The Prescription Drug Affordability Board Stakeholder Council will have a regularly scheduled meeting on February 23, 2026 at 2:00 PM ET. Meeting information can be found here.​
  

• Informational Hearing Notice: The Maryland Prescription Drug Affordability Board is evaluating its cost review study process (COMAR 14.01.04.01, et seq.) and policy review procedures (COMAR 14.01.05.01, et seq.), and invites public comment on these procedures. More information can be found here. These hearings will take place on February 10, 2026.
• Written Comment Request: 
  I​n accordance with COMAR 14.01.05.06A and 14.01.01.05B(4), the Prescription Drug Affordability Board requests public written comment on the revised framework documents for Ozempic and Trulicity. 
  Comments will be accepted through close of business February 17, 2026. More information can be found here​. ​
• Join the PDAB Mailing List here​.​